Archives dicerna-pharmaceuticals

by in
Entry Author Date Location
East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More 06/12/15 Boston
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor 04/14/15 National
Big Events, Exits Raising Boston’s Innovation Profile at Year’s End 12/12/14 Boston
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More 11/21/14 Boston
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
With $310M and Public Investors Aboard, Is a Juno IPO Next? 08/05/14 Seattle
Radius Health Yanks IPO, Cites Market Conditions 05/09/14 Boston
Biotech IPO Slump Deepens as Alder Prices Below Range 05/08/14 Seattle
East Coast Biotech Roundup: Dicerna, J&J, Neurophage, & More 01/31/14 Boston
Dicerna Prices Upsized IPO at $15 Per Share, Starts Trading Thursday 01/29/14 Boston
East Coast Biotech Roundup: Scholar Rock, Dicerna, Eleven, & More 01/03/14 Boston
Dicerna Joins Biotech IPO Queue, Plans $69M Raise 01/02/14 Boston
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
Dicerna Snags $60M as RNAi Heats Up Again 08/01/13 Boston
Dicerna Pharmaceuticals Obtains $60,000,000 Series C Funding 08/01/13 Boston
Shedding Baggage, Alnylam Turns a Corner 02/21/13 Boston
Infinity & Dicerna Among the Week’s Life Sciences Newsmakers 08/10/12 Boston
Boston Xconomists and Area Innovators Gather for Special Xconomy Event: The Photos 10/13/11 Boston
Tokai Snaps Up $23M From Novartis and Apple Tree to Challenge Leaders in Prostate Cancer 09/20/11 Boston
Alnylam CEO Looks to the Future, Dicerna Plumps Up Kyowa Hakko Pact, Momenta Sells $57.4M Stock Offering, & More Boston-Area Life Sciences News 12/10/10 Boston
Dicerna Expands Kyowa Hakko Pact 12/07/10 Boston
Trimble Scoops Up ThingMagic, Resolvyx Sells Option to Celtic Therapeutics, GSK Venture Arm Puts $4M into Dicerna, & More Boston-Area Deals News 10/27/10 Boston
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News 10/22/10 Boston
Dicerna Pharmaceuticals Secures $4,000,000 Series B Round 10/22/10 Boston
Dicerna Gets Glaxo’s SR One to Join Investor Syndicate 10/21/10 Boston
Dicerna, Actifio Headline Top 10 Third Quarter VC Deals in Massachusetts 10/18/10 Boston
Alkermes Drug Approved for Opioid Addiction, Genzyme Faces Shareholder Lawsuits, NinePoint Gets $33M, & More Boston-Area Life Sciences News 10/15/10 Boston
Mike Huckman, Former CNBC Reporting Ace, Joins Stellar Lineup at Boston’s War on Cancer 10/14/10 Boston
Where Will the Next Gleevec Come From? Xconomy Forum Looks At the Edge of Cancer R&D 10/05/10 Boston
August Startup Financings in MA Rose Slightly to $143M, With Plenty of Smaller Deals 09/21/10 Boston
Page 1 of 2 next page »